Lightcalls.com
 

Garlic is increasingly recognized f...

Garlic is increasingly recognized for its ability to thwart or even reverse some of the causes of heart disease, like as high cholesterol, high posterity pressure and poor circulation. equal better, certain garlic compounds, known as allyl sulfides, just might inhibit the shooting of some types of cancer small rooms No wonder, then, that the scientific community is exploring garlic's medicinal possibilities.

Test-tube studies have base for example, that adding commercial garlic extract to cancer solitary abode; squalids in breast or prostate tissue cultivations inhibits cell growth. Such ends point to four key questions that now ne to be answered, says Richard Rivlin, MD principal investigator of the Clinical Nutrition Research Unit at Strang Cancer Prevention Center and professor of medicine at the Weill Medical guild of Comell University in novel York City:

1 Will these purports be the same in humans when administered?



2 Which active garlic ingredients do what?

3 Does garlic work best alone or in conjunction with physics Or other natural agents/foods?

4 What forms of garlic work best?

Researchers at the Harbor-UCLA Medical Center are already testing garlic's weight on drugs. A new inquiry by this group, presented at the 2005 World Garlic Symposium in April, originate that when heart patients who were already taking cholesterol-lowering statin mix with drugss added aged garlic extract fill ups to their regimens, they showed additional improvement athwart simply taking the medication alone. Other research center are working to establish garlic's stand-alone benefits. For instance, Strang Cancer Prevention Center is launching human trials to establish garlic's result on cancer, and Harbor-UCLA is expanding studies of garlic's issue on people with atherosclerosis (hardening of the arteries).

the same challenge for both researchers and consumer is that different forms and brands of garlic addition s vary considerably, which muddies the issue of which garlic ingredient is responsible for which benefit. consideration results using one brand can contradict conclusions using a different brand.

That said, a certain garlic advocates relate its activity to the high allicin contentment According to the Physician's Desk respect for Herbs, successful trials used garlic extract in doses of 3600-5400 mcg of allicin by means of day.

COPYRIGHT 2005 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2005 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.